We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
-28.98%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$29.4M
AUM Growth
-$10.8M
Cap. Flow
+$998K
Cap. Flow %
3.39%
Top 10 Hldgs %
100%
Holding
1
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$998K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.38B
$29.4M 100%
5,944,761
+180,000
+3% +$998K

Similar funds

Summer Road's Q1 2022 Portfolio in Review

As of Q1 2022, Summer Road held 1 position worth $29.4M, down 27% from $40.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road deployed $998K of net new capital in Q1 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road added most to Ocular Therapeutix in Q1 2022, an estimated $998K increase.
  • Summer Road's ten largest holdings make up 100% of its $29.4M portfolio in Q1 2022.
  • Summer Road opened 0 new positions and closed 0 in Q1 2022.
  • Summer Road's portfolio value fell 27% quarter-over-quarter to $29.4M.

Based on Summer Road's 13F filing for Q1 2022, filed 13 May 2022.